Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Expanding use of Amarin heart drug Vascepa unanimously backed by USFDA panel

      Expanding use of Amarin heart drug Vascepa unanimously backed by USFDA panel

      Medical Dialogues Bureau17 Nov 2019 9:15 AM IST
      The USFDA panel voted 16-0 in favour of expanding approval, potentially opening up a multi-billion dollar opportunity for Amarin which has only one...
      Cipla gets 4 USFDA observations for Patalganga facility

      Cipla gets 4 USFDA observations for Patalganga facility

      Medical Dialogues Bureau16 Nov 2019 12:56 PM IST
      New Delhi: Drug maker Cipla recently informed that the United States Food and Drug Administration (USFDA) conducted a routine cGMP (current Good...
      Cadila Healthcare Moraiya plant gets USFDA warning letter for significant violations of CGMP

      Cadila Healthcare Moraiya plant gets USFDA warning letter for significant violations of CGMP

      Medical Dialogues Bureau16 Nov 2019 11:11 AM IST
      Cadila Healthcare failed to clean, maintain, and, as appropriate for the nature of the drug, sanitize and/or sterilise equipment and utensils at...
      Natco Pharma Vizag facility begins production

      Natco Pharma Vizag facility begins production

      Medical Dialogues Bureau16 Nov 2019 9:35 AM IST
      The Visakhapatnam facility was a part of the Special Economic Zone (SEZ) and intended to cater primarily to the U.S. and other international markets,...
      Bharat Biotech arm Chiron Behring relaunches rabies vaccine as Chirorab

      Bharat Biotech arm Chiron Behring relaunches rabies vaccine as Chirorab

      Medical Dialogues Bureau16 Nov 2019 9:30 AM IST
      The immunogenicity, efficacy, and safety of Chirorab has been assessed in several clinical trials in pre- and post-exposure regimens, using both...
      Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

      Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

      Medical Dialogues Bureau16 Nov 2019 9:20 AM IST
      New Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
      Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

      Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

      Medical Dialogues Bureau16 Nov 2019 9:15 AM IST
      The profit after tax works out to Rs 43 crore in Q2 FY20, up 43.7 per cent from Rs 30 crore in Q2 FY19.Mumbai: Leading diagnostic service provider...
      NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

      NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

      Medical Dialogues Bureau15 Nov 2019 4:29 PM IST
      New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
      Zydus Cadila acquires 15 pc stake in Zydus Noveltech, Zydus Technologies for over Rs 1 crore

      Zydus Cadila acquires 15 pc stake in Zydus Noveltech, Zydus Technologies for over Rs 1 crore

      Medical Dialogues Bureau15 Nov 2019 3:21 PM IST
      New Delhi: Drugmaker, Zydus Cadila also known as Cadila Healthcare Ltd.(CHL) has recently announced that the company has acquired 15 per cent stake in...
      JB Chemicals Q2 PAT jumps 82 pc at Rs 94 crore

      JB Chemicals Q2 PAT jumps 82 pc at Rs 94 crore

      Medical Dialogues Bureau15 Nov 2019 9:32 AM IST
      Mumbai: JB Chemicals and Pharmaceuticals Ltd on Tuesday reported 82 per cent jump in its profit after tax during the second quarter at Rs 94 crore...
      Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

      Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

      Medical Dialogues Bureau15 Nov 2019 9:30 AM IST
      The illegally imported drugs - made by Alpha Pharma in India - were shipped using Dhillon's contacts. Once in the UK they would be distributed by...
      Health authorities introduce JnJ new Ebola vaccine in Congo

      Health authorities introduce JnJ new Ebola vaccine in Congo

      Medical Dialogues Bureau15 Nov 2019 9:15 AM IST
      New Delhi: Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson & Johnson, aid group MSF said on Thursday,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok